Clincosm LogoSign in Get a demo

diabetes mellitus, type 2

Showing NaN - NaN of 235
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial in United States (Semaglutide 2.4 mg, Cagrilintide 2.4 mg, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Semaglutide 2.4 mg
  • +3 more
  • Birmingham, Alabama
  • +17 more
Mar 14, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • Montgomery, Alabama
  • +444 more
Mar 11, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo (semaglutide))

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +128 more
Feb 14, 2022

Diabetes, Type 2 Trial in Worldwide (Semaglutide)

Withdrawn
  • Diabetes Mellitus, Type 2
  • Buena Park, California
  • +24 more
Feb 2, 2022

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin glargine U100)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • Insulin glargine U100
  • Walnut Creek, California
  • +37 more
Jan 6, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Insulin degludec, Insulin glargine)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Insulin degludec
  • Insulin glargine
  • Anniston, Alabama
  • +228 more
Jan 6, 2022

Diabetes, Diabetes, Type 2 Trial in Worldwide (Faster-acting insulin aspart, Insulin aspart, Insulin degludec)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Faster-acting insulin aspart
  • +3 more
  • Concord, California
  • +166 more
Jan 6, 2022

Second Line Therapy Medications in Diabetes

Recruiting
  • Diabetes Mellitus, Type 2
  • Wilmington, Delaware
  • +4 more
Dec 22, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, , metformin)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +184 more
Jul 1, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (Semaglutide, Placebo)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Andalusia, Alabama
  • +71 more
Jul 1, 2021

Diabetes, Type 2 Trial in Worldwide (LY2944876, Exenatide extended-release, Placebo)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Concord, California
  • +50 more
May 25, 2021

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • Insulin Glargine
  • Anaheim, California
  • +42 more
Mar 5, 2021

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo (insulin 287), Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +5 more
  • Lancaster, California
  • +48 more
Mar 5, 2021

NAFLD, Diabetes, Type 2, Hypertriglyceridemia Trial in Canada, United States (Placebo, ISIS 703802 40 mg, ISIS 703802 80 mg)

Completed
Has Results
  • NAFLD
  • +3 more
  • Placebo
  • +3 more
  • Chandler, Arizona
  • +41 more
Jan 28, 2021

Diabetes, Diabetes, Type 2 Trial in Worldwide (semaglutide, oral )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Tucson, Arizona
  • +102 more
Jan 14, 2021

Diabetes, Type 2 Trial in Worldwide (Vildagliptin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Pell City, Alabama
  • +175 more
Dec 11, 2020

Diabetes, Type 2, Renal Insufficiency Trial in United States (vildagliptin, sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Renal Insufficiency
  • Mobile, Alabama
  • +86 more
Dec 11, 2020

Diabetes, Type 2 Trial in United States (vildagliptin, Sitagliptin)

Completed
  • Diabetes Mellitus, Type 2
  • Mobile, Alabama
  • +78 more
Dec 11, 2020

Diabetes, Type 2 Trial in Worldwide (Albiglutide, Insulin Glargine and Insulin Lispro)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Searcy, Arkansas
  • +157 more
Nov 13, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +81 more
Oct 26, 2020

Diabetes, Type 2 Trial in Louisville, Dallas (Exenatide, Albiglutide)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Louisville, Kentucky
  • +1 more
Oct 8, 2020

Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, alpha-glucosidase inhibitors, DPP-4 inhibitors)

Completed
Has Results
  • Diabetes
  • Diabetes Mellitus, Type 2
  • Birmingham, Alabama
  • +231 more
Jun 16, 2020

Diabetes, Type 2 Trial in Worldwide (Dulaglutide)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Chandler, Arizona
  • +207 more
May 28, 2020

Diabetes, Type 2, Non-Alcoholic Fatty Liver Disease Trial in Canada, United States (BFKB8488A, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Non-Alcoholic Fatty Liver Disease
  • Anniston, Alabama
  • +17 more
Mar 25, 2020

Diabetes, Type 2 Trial in Worldwide (Ticagrelor 60 mg, Ticagrelor )

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Ticagrelor 60 mg
  • Ticagrelor placebo
  • Alexander City, Alabama
  • +1241 more
Mar 4, 2020